T. 02-580-4039
Ms. Youngyoon Lee is a patent attorney and partner at LEE & MOCK IP. After passing the Korean Patent Attorney Bar Examination in 2013, she has specialized in intellectual property (IP) matters across the biotechnology and life sciences sectors, including biosimilars, gene therapies, AI-driven drug discovery, cosmetics, functional foods, and microorganisms.
In particular, Ms. Lee serves a diverse clientele in the pharmaceutical and cosmetics fields, ranging from major domestic corporations and mid-sized enterprises to startups. She provides tailored consulting services that blend technical expertise with a keen business perspective, offering freedom-to-operate (FTO) analyses, infringement reviews, and IP strategy development, particularly at early R&D stages. Furthermore, she brings extensive hands-on experience across the entire IP lifecycle, from domestic and international patent applications to Office Action responses and dispute resolution. Drawing on this experience, she delivers integrated solutions to ensure that her clients\\\' core technologies are protected with strong and enforceable rights in the global market.
In addition, leveraging her professional working proficiency in Chinese, she offers specialized expertise in China-related IP matters, including advising on Chinese patent applications and reviewing patent specifications in Chinese.
EDUCATION
- Konkuk University (B.S. in Molecular biotechnology, 2012)
WORK EXPERIENCE
- LEE & MOCK IP (2016-Present)
- DANA Patent Law Firm (2013-2016)
ADMISSION
- Patent Attorney, Republic of Korea (2013)
LANGUAGES
- Korean, English, Chinese
KEY ACTIVITIES
MEMBERSHIP
- Korean Patent Attorney Association (KPAA)
REPRESENTATIVE MATTERS
- - Numerous freedom-to-operate (FTO) analyses for peptide pharmaceuticals, antibody therapeutics, protein drugs, gene therapies, cosmetics, and microorganisms
- - Technology valuation for probiotics technology (2022)
- - Technology valuation for RNAi therapeutics technology (2020)
- - Patent strategy consulting on antibody therapeutics for Seoul National University College of Medicine (2020)
- - IP consulting for the Startup Global Expansion Voucher Program with the Korea Institute of Intellectual Property Strategy (KISTA) (2019)
- - International IP dispute prevention consulting for the Korea Intellectual Property Protection Agency (KOIPA) (2016)
- - Patent consulting on proprietary new drug technologies under the Health & Medical TLO Expert Dispatch Program by the Korea Drug Development Fund (KDDF) (2014-2015)
- - Bio patent trend analysis under the Government R&D Patent Trend Survey Project for the Korea Institute of Intellectual Property Strategy (KISTA) (2014)